Exchange: NASDAQ·Updated 04:44 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 06

Estimated EPS

-$0.29

Reported EPS

-$0.25

Surprise

+14.62%

Estimated Rev

$20.25M

Reported Rev

$21.49M

Surprise

+6.12%

• Reported GAAP EPS of -$5.00 up 34.21% YoY • Reported revenue of $21.7M up 17.83% YoY • AVITA Medical raised its full-year 2026 net revenue guidance range to $86 million to $89 million, reflecting confidence in continued commercial execution, and expects to reach cash flow breakeven in Q4 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.24
--
--
N/A
Q2 '26
-$0.29
-$0.25
14.62%
BEAT
Q1 '26
-$0.29
-$0.35
-19.86%
MISSED
Q4 '25
-$0.36
-$0.38
-4.27%
MISSED
Q3 '25
-$0.30
-$0.46
-55.56%
MISSED

Advertisement|Remove ads.